Delineating Spatial Heterogeneity of Tumor Mutational Burden (TMB) Counts in Pulmonary Adenocarcinoma

被引：0
|
作者：
Kazdal, D. [1 ]
Allgaeuer, M. [1 ]
Budczies, J. [1 ]
Kriegsmann, M. [1 ]
Leichsenring, J. [1 ]
Volckmar, A. [1 ]
Kirchner, M. [1 ]
Neumann, O. [1 ]
Brandt, R. [1 ]
Rempel, E. [1 ]
Tala, S. [1 ]
Harms, A. [1 ]
Ploegler, C. [1 ]
Von Winterfeld, M. [1 ]
Penzel, R. [1 ]
Schirmacher, P. [1 ]
Endris, V. [1 ]
Stenzinger, A. [1 ]
机构：
[1] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
tumor mutational burden (TMB); Intra tumor heterogeneity; lung adenocarcinoma;
D O I：
10.1016/j.jtho.2019.08.916
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-13
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [41] MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma
    Lv, Yufeng
    Huang, Zhong
    Lin, Yan
    Fang, Yuan
    Chen, Zhichao
    Pan, Lili
    Zhang, Yanxian
    Xu, Zihai
    ONCOIMMUNOLOGY, 2019, 8 (10):
  • [42] TUMORS WITH HIGHER HETEROGENEITY WERE ASSOCIATED WITH SUPERIOR SURVIVAL OUTCOME AMONGST STAGE I LUNG CANCER PATIENTS WITH LOW TUMOR MUTATIONAL BURDEN (TMB)
    Fridland, Stanislav
    Chae, Young Kwang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A79 - A79
  • [43] Tumor Mutational Burden (TMB) Scoring in Pediatric Tumors Using a Comprehensive Clinical Genomics Sequencing Approach
    Cardenas, M.
    Wang, L.
    Ma, J.
    Payne-Turner, D.
    Gu, J.
    Conn, P.
    Wallace, R.
    Howell, S.
    Neary, J.
    Pastor, V.
    Shi, Z.
    Smith, M.
    Haltom, K.
    Shumaker, S.
    Messler, K.
    Koo, S.
    Blackburn, P.
    Liu, Y.
    Eldomery, M.
    Rusch, M.
    Furtado, L.
    Klco, J.
    Mallampati, S.
    Wheeler, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S82 - S82
  • [44] Tumor mutational burden (TMB) and co-existing actionable mutations in biliary tract cancers (BTC).
    Jain, Apurva
    Shroff, Rachna T.
    Zuo, Mingxin
    Weatherly, Jacqueline
    Meric-Bernstam, Funda
    Isaacs, Randi
    Ali, Siraj Mahamed
    Bekaii-Saab, Tanios S.
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer.
    Natesan, Divya
    Martell, Henry
    Devine, Patrick
    Stohr, Bradley A.
    Grenert, James P.
    Van Ziffle, Jessica
    Joseph, Nancy M.
    Bastian, Boris C.
    Umetsu, Sarah E.
    Onodera, Courtney
    Chan, Emily
    Desai, Arpita
    Wong, Anthony C.
    Porten, Sima P.
    Chou, Jonathan
    Friedlander, Terence W.
    Small, Eric Jay
    Fong, Lawrence
    Sweet-Cordero, Eric Alejandro
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Tumor mutational burden profile (TMB) of oncogenic driver mutations in non small cell lung cancer
    Walker, Paul
    Sharma, Nitika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [47] Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians
    Allgaeuer, Michael
    Budczies, Jan
    Christopoulos, Petros
    Endris, Volker
    Lier, Amelie
    Rempel, Eugen
    Volckmar, Anna-Lena
    Kirchner, Martina
    von Winterfeld, Moritz
    Leichsenring, Jonas
    Neumann, Olaf
    Froehling, Stefan
    Penzel, Roland
    Thomas, Michael
    Schirmacher, Peter
    Stenzinger, Albrecht
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 703 - 715
  • [48] Atezolizumab in patients (pts) with tumor mutational burden (TMB)-high tumors from the TAPISTRY trial.
    Dziadziuszko, Rafal
    Barlesi, Fabrice
    Kim, Jeong Eun
    Gadgeel, Shirish M.
    Krzakowski, Maciej
    Jeong, Jae Ho
    Daniele, Gennaro
    Chen, David
    Hu, Youyou
    Wilson, Timothy R.
    Simmons, Brian P.
    Thomas, David Morgan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA2509 - LBA2509
  • [49] Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors
    Kao, Chester
    Powers, Eric
    Datto, Michael B.
    Green, Michelle
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Clarke, Jeffrey Melson
    Strickler, John H.
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [50] Defining tissue requirements for a reliable detection of tumor mutational burden (TMB) in clinical FFPE samples.
    Schildhaus, Hans-Ulrich
    Herold, Thomas
    Worm, Karl
    Stoss, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345